Joseph W Ochterski

Title: Joseph W. Ochterski: Innovator in Pharmaceutical Chemistry

Introduction

Joseph W. Ochterski is a notable inventor based in Middlefield, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate ligand binding to histamine H3 receptors. With a total of 2 patents, his work has implications for treating various disorders in both humans and animals.

Latest Patents

Ochterski's latest patents include "Dipiperazinyl ketones and related analogues" and "Thiazole amides, imidazole amides and related analogues." The first patent focuses on compounds that can modulate ligand binding to histamine H3 receptors, which are useful in treating a variety of disorders. These compounds can be utilized in pharmaceutical compositions and therapeutic methods, including receptor localization studies. The second patent also addresses compounds that modulate ligand binding to histamine H3 receptors, specifically targeting central nervous system disorders. These compounds can be administered alone or in combination with other CNS agents to enhance their effects.

Career Highlights

Joseph W. Ochterski is associated with Neurogen Corporation, where he continues to innovate in the field of pharmaceutical research. His work has been instrumental in advancing the understanding and treatment of disorders related to histamine H3 receptors.

Collaborations

Ochterski has collaborated with notable colleagues, including Linghong Xie and Yang Gao, contributing to the advancement of research in his field.

Conclusion

Joseph W. Ochterski's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a significant inventor in the industry. His work continues to impact the treatment of various disorders, showcasing the importance of research and innovation in healthcare.